Targeting these pathways by inhibition of IDO or supplementation of CKD patients with amino acids, antioxidants such as vitamins B6 and C, or IPA could provide effective treatment options for slowing down the progression of kidney disease and improving the allograft function and viability post-transplant. The gene discussed is IDO1; the disease is chronic kidney disease.